225 related articles for article (PubMed ID: 33579340)
1. Neoadjuvant irradiation of retroperitoneal soft tissue sarcoma with ions (Retro-Ion): study protocol for a randomized phase II pilot trial.
Seidensaal K; Kieser M; Hommertgen A; Jaekel C; Harrabi SB; Herfarth K; Mechtesheimer G; Lehner B; Schneider M; Nienhueser H; Fröhling S; Egerer G; Debus J; Uhl M
Trials; 2021 Feb; 22(1):134. PubMed ID: 33579340
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant irradiation of extremity soft tissue sarcoma with ions (Extrem-ion): study protocol for a randomized phase II pilot trial.
Brügemann D; Lehner B; Kieser M; Krisam J; Hommertgen A; Jaekel C; Harrabi SB; Herfarth K; Mechtesheimer G; Sedlaczek O; Egerer G; Geisbüsch A; Uhl M; Debus J; Seidensaal K
BMC Cancer; 2022 May; 22(1):538. PubMed ID: 35550036
[TBL] [Abstract][Full Text] [Related]
3. Randomized phase II trial of hypofractionated proton versus carbon ion radiation therapy in patients with sacrococcygeal chordoma-the ISAC trial protocol.
Uhl M; Edler L; Jensen AD; Habl G; Oelmann J; Röder F; Jäckel O; Debus J; Herfarth K
Radiat Oncol; 2014 Apr; 9():100. PubMed ID: 24774721
[TBL] [Abstract][Full Text] [Related]
4. Prospective phase II trial of preoperative hypofractionated proton therapy for extremity and truncal soft tissue sarcoma: the PRONTO study rationale and design.
Gogineni E; Chen H; Hu C; Boudadi K; Engle J; Levine A; Deville C
Radiat Oncol; 2024 May; 19(1):56. PubMed ID: 38745333
[TBL] [Abstract][Full Text] [Related]
5. Update on Dosing and Fractionation for Neoadjuvant Radiotherapy for Localized Soft Tissue Sarcoma.
Roohani S; Wiltink LM; Kaul D; Spałek MJ; Haas RL
Curr Treat Options Oncol; 2024 Apr; 25(4):543-555. PubMed ID: 38478330
[TBL] [Abstract][Full Text] [Related]
6. A clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma.
Roeder F; Schulz-Ertner D; Nikoghosyan AV; Huber PE; Edler L; Habl G; Krempien R; Oertel S; Saleh-Ebrahimi L; Hensley FW; Buechler MW; Debus J; Koch M; Weitz J; Bischof M
BMC Cancer; 2012 Jul; 12():287. PubMed ID: 22788989
[TBL] [Abstract][Full Text] [Related]
7. Preoperative hypofractionated radiotherapy for soft tissue sarcomas: a systematic review.
Roohani S; Ehret F; Kobus M; Flörcken A; Märdian S; Striefler JK; Rau D; Öllinger R; Jarosch A; Budach V; Kaul D
Radiat Oncol; 2022 Sep; 17(1):159. PubMed ID: 36104789
[TBL] [Abstract][Full Text] [Related]
8. NORAD01-GRECCAR16 multicenter phase III non-inferiority randomized trial comparing preoperative modified FOLFIRINOX without irradiation to radiochemotherapy for resectable locally advanced rectal cancer (intergroup FRENCH-GRECCAR- PRODIGE trial).
Brouquet A; Bachet JB; Huguet F; Karoui M; Artru P; Sabbagh C; Lefèvre JH; Vernerey D; Mariette C; Vicaut E; Benoist S;
BMC Cancer; 2020 May; 20(1):485. PubMed ID: 32471382
[TBL] [Abstract][Full Text] [Related]
9. Ion Prostate Irradiation (IPI) - a pilot study to establish the safety and feasibility of primary hypofractionated irradiation of the prostate with protons and carbon ions in a raster scan technique.
Habl G; Hatiboglu G; Edler L; Uhl M; Krause S; Roethke M; Schlemmer HP; Hadaschik B; Debus J; Herfarth K
BMC Cancer; 2014 Mar; 14():202. PubMed ID: 24641841
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled phase III study comparing hadrontherapy with carbon ions versus conventional radiotherapy - including photon and proton therapy - for the treatment of radioresistant tumors: the ETOILE trial.
Balosso J; Febvey-Combes O; Iung A; Lozano H; Alloh AS; Cornu C; Hervé M; Akkal Z; Lièvre M; Plattner V; Valvo F; Bono C; Fiore MR; Vitolo V; Vischioni B; Patin S; Allemand H; Gueyffier F; Margier J; Guerre P; Chabaud S; Orecchia R; Pommier P
BMC Cancer; 2022 May; 22(1):575. PubMed ID: 35606739
[TBL] [Abstract][Full Text] [Related]
11. Acute Toxicity and Quality of Life in Patients With Prostate Cancer Treated With Protons or Carbon Ions in a Prospective Randomized Phase II Study--The IPI Trial.
Habl G; Uhl M; Katayama S; Kessel KA; Hatiboglu G; Hadaschik B; Edler L; Tichy D; Ellerbrock M; Haberer T; Wolf MB; Schlemmer HP; Debus J; Herfarth K
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):435-443. PubMed ID: 27084659
[TBL] [Abstract][Full Text] [Related]
12. Carbon ion reirradiation compared to intensity-modulated re-radiotherapy for recurrent head and neck cancer (CARE): a randomized controlled trial.
Held T; Lang K; Regnery S; Weusthof K; Hommertgen A; Jäkel C; Tonndorf-Martini E; Krisam J; Plinkert P; Zaoui K; Freudlsperger C; Moratin J; Krauss J; Harrabi SB; Herfarth K; Debus J; Adeberg S
Radiat Oncol; 2020 Aug; 15(1):190. PubMed ID: 32758267
[TBL] [Abstract][Full Text] [Related]
13. Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma.
Blattmann C; Oertel S; Schulz-Ertner D; Rieken S; Haufe S; Ewerbeck V; Unterberg A; Karapanagiotou-Schenkel I; Combs SE; Nikoghosyan A; Bischof M; Jäkel O; Huber P; Kulozik AE; Debus J
BMC Cancer; 2010 Mar; 10():96. PubMed ID: 20226028
[TBL] [Abstract][Full Text] [Related]
14. Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial.
Guadagnolo BA; Bassett RL; Mitra D; Farooqi A; Hempel C; Dorber C; Willis T; Wang WL; Ratan R; Somaiah N; Benjamin RS; Torres KE; Hunt KK; Scally CP; Keung EZ; Satcher RL; Bird JE; Lin PP; Moon BS; Lewis VO; Roland CL; Bishop AJ
Lancet Oncol; 2022 Dec; 23(12):1547-1557. PubMed ID: 36343656
[TBL] [Abstract][Full Text] [Related]
15. Preoperative Radiotherapy in Patients With Primary Retroperitoneal Sarcoma: EORTC-62092 Trial (STRASS) Versus Off-trial (STREXIT) Results.
Callegaro D; Raut CP; Ajayi T; Strauss D; Bonvalot S; Ng D; Stoeckle E; Fairweather M; Rutkowski P; van Houdt WJ; Gelderblom H; Sangalli C; Hayes A; Honoré C; Gladdy RA; Fau M; Haas R; Tzanis D; Miah AB; Chung P; Baldini EH; Marreaud S; Litiere S; Swallow CJ; Gronchi A
Ann Surg; 2023 Jul; 278(1):127-134. PubMed ID: 35833413
[TBL] [Abstract][Full Text] [Related]
16. Glioblastoma radiotherapy using Intensity modulated Radiotherapy (IMRT) or proton Radiotherapy-GRIPS Trial (Glioblastoma Radiotherapy via IMRT or Proton BeamS): a study protocol for a multicenter, prospective, open-label, randomized, two-arm, phase III study.
König L; Jäkel C; von Knebel Doeberitz N; Kieser M; Eberle F; Münter M; Debus J; Herfarth K
Radiat Oncol; 2021 Dec; 16(1):240. PubMed ID: 34930368
[TBL] [Abstract][Full Text] [Related]
17. Adenoid cystic Carcinoma and Carbon ion Only irradiation (ACCO): Study protocol for a prospective, open, randomized, two-armed, phase II study.
Lang K; Adeberg S; Harrabi S; Held T; Kieser M; Debus J; Herfarth K
BMC Cancer; 2021 Jul; 21(1):812. PubMed ID: 34266402
[TBL] [Abstract][Full Text] [Related]
18. Randomised trial of proton vs. carbon ion radiation therapy in patients with low and intermediate grade chondrosarcoma of the skull base, clinical phase III study.
Nikoghosyan AV; Rauch G; Münter MW; Jensen AD; Combs SE; Kieser M; Debus J
BMC Cancer; 2010 Nov; 10():606. PubMed ID: 21050498
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma.
Keung EZ; Lazar AJ; Torres KE; Wang WL; Cormier JN; Ashleigh Guadagnolo B; Bishop AJ; Lin H; Hunt KK; Bird J; Lewis VO; Patel SR; Wargo JA; Somaiah N; Roland CL
BMC Cancer; 2018 Sep; 18(1):913. PubMed ID: 30249211
[TBL] [Abstract][Full Text] [Related]
20. Prostate bed irradiation with alternative radio-oncological approaches (PAROS) - a prospective, multicenter and randomized phase III trial.
Koerber SA; Katayama S; Sander A; Jaekel C; Haefner MF; Debus J; Herfarth K
Radiat Oncol; 2019 Jul; 14(1):122. PubMed ID: 31291969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
